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Abstract 
 
Fragile X syndrome (FXS) is the most common form of inherited mental 
retardation in humans.  FXS is caused by loss of the Fragile X Mental Retardation Protein 
(FMRP), an important regulator of neuronal mRNA translation.  Patients with FXS 
display cognitive deficits including memory problems.  Protein synthesis-dependent long-
term changes in synaptic plasticity are involved in the establishment and maintenance of 
long-term memory.  One prevalent theory of FXS pathology predicts that FMRP is 
required to negatively regulate the translation of important mRNAs at the synapse.  We 
are investigating microRNAs (miRNAs) as a potential regulator of synaptic FMRP-
regulated mRNAs that have previously been described as being crucial to the process of 
synaptic plasticity. 
The general hypothesis underlying this thesis is that FMRP may negatively 
regulate the expression of futsch (the Drosophila homologue of the microtubule-
associated protein gene MAP1B) via the miRNA pathway.  The first step we took in 
testing this hypothesis was to confirm that futsch is subject to miRNA-mediated 
translational control.  Using in silico target analysis, we predicted that several neuronally 
expressed miRNAs target the futsch mRNA 3’UTR and repress expression of Futsch 
protein.  Then, using an in vitro luciferase reporter system, we showed that miR-315 and 
members of the miR-9 family selectively down-regulated futsch reporter translation.  We 
 iii 
have confirmed by site- directed mutagenesis that the miRNA interaction with the futsch 
3’UTR is specific to the miRNA seed region binding site.  Interestingly, reduction of 
FMRP levels by RNAi had no effect on futsch 3’UTR reporter expression.  Together, 
these data suggest regulation of futsch expression by the miRNA pathway might be 
independent of FMRP activity.  However, additional experiments need to be completed to 
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Chapter One: Introduction 
1.1 Overview 
Fragile X syndrome (FXS) is the most common form of inherited mental 
retardation in humans, and is a major genetic cause of autism (Bassell and Warren, 2008). 
It has an estimated incidence of 1 in 4,000 men and 1 in 8,000 women (Warren et al., 
1991).  FXS is caused by loss of the Fragile X Mental Retardation Protein (FMRP), an 
important regulator of neuronal mRNA translation.  The absence of FMRP is due to the 
transcriptional inactivation of the fragile X mental retardation 1 (FMR1) gene, which 
results from an unstable expansion of a CGG trinucleotide repeat in its 5’ untranslated 
region (UTR) (Jin and Warren, 2003).  Transcriptional repression of the FMR1 gene 
occurs when the CpG islands and the CGG repeats are hypermethylated.  A current 
model postulates that FMRP regulates mRNA transport and local protein synthesis in 
response to activated metabotropic glutamate receptors (mGluRs) (Figure 1; Jin et al., 
2004b).  The activation of group I mGluRs (mGluR1 and mGluR5) stimulates the 
synthesis of FMRP in synapses (Figure 1; Weiler et al., 1997).  It is believed that one 
major function of FMRP at the cell synapse is to offset local translation of specific 
mRNAs following mGluR stimulation (Krueger et al., 2011).  While a significant amount 
of progress has been made towards understanding these processes, there are still several 






FIGURE 1.  Model for mRNA regulation by FMRP. After translation, FMRP 
dimerizes in the cytoplasm then is imported to the nucleus where it forms a messenger 
ribonucleoprotein (mRNP) complex with specific hairpin structured RNA transcripts and 
other proteins.  The FMRP–mRNP complex is then transported to the cytoplasm where it 
can either associate directly with the polyribosomes or interact with the RNA-induced 
silencing complex (RISC).  The FMRP-mRNP complexes can regulate protein synthesis 
in the cell body, or they can be transported to the dendrites to regulate local protein 
synthesis upon metabotropic glutamate stimulation.  In the mGluR theory of FXS 
pathogenesis, one essential function of FMRP is to repress the expression of specific 
mRNAs at the synapse.  Most of these mRNAs remain uncharacterized.  FMRP=green 
hexagon, Ribosomes = purple ovals, RISC = red star, newly synthesized protein = string 
of blue circles, mGluR= orange oval.  Figure adapted from Jin et al. (2004b). 
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regulated by FMRP?  Second, how does FMRP regulate the expression of these target 
mRNAs?  The second question will be addressed in the hypothesis outlined below. 
 
1.2 Genetics of FXS 
FXS has an unusual genetic inheritance pattern referred to as the Sherman 
Paradox.  In the 1980s, Sherman showed that nonpenetrant male carriers exist in fragile X 
syndrome families, which is an unusual observation for an X-linked disorder.  Symptom-
free (nonpenetrant) males can transmit their alleles to nonpenetrant daughters who can 
then bear symptomatic (penetrant) male offspring (Sherman et al., 1985).  Affected 
individuals display a phenotype of a “fragile site” or unstaining gap on the metaphase X 
chromosome that segregates with the mutant gene (Penagarikano et al., 1991). FMR1, the 
gene responsible for FXS, has been mapped to the fragile site on the X chromosome. 
Cloned and first identified in 1991, (Verkerk et al., 1991), it was one of the first 
trinucleotide repeats linked to a disease.  Interestingly, unlike most disease-associated 
trinucleotide repeats, the expansion responsible for FXS occurs in a non-coding region of 
the gene (in this case, the 5’UTR of FMR1) (Jin et al., 2004b). 
 
1.3 Polynucleotide Expansions in FMR1 
An extreme CGG polynucleotide expansion (>200 repeats) is the causative 
mutation in 99% of individuals with FXS (Jin et al., 2004b).  However, there is a great 
deal of variation in the number of CGG repeats in the 5’UTR of FMR1 in humans (Figure 









FIGURE 2.  Schematic representation of the FMR1 gene and CGG polynucleotide 
expansions in the FMR1 5’UTR.  There are 17 exons in the FMR1 gene that can 
undergo alternative splicing.  Expansions of the CGG repeat greater than 200 are 
characterized as a “full mutation”, expansions with fewer than 200 CGG repeats but 
significantly more than average are characterized as a “premutation”.  Premutation alleles 
can lead to the development of FXTAS (males) or FXPOI (females) later in life.  Full 






containing between 6 and 54 repeats, with 30 repeats being most common.  Normal 
FMR1 alleles are usually transmitted stably, but will occasionally gain or lose a few 
repeats.  This variation leads to a pool of people with elevated repeat numbers that could 
eventually evolve premutations (Penagarikano et al., 2007).  A second class of people has 
“premutation” alleles with significantly more than average, but fewer than 200, CGG 
repeats.  Premutation alleles are unstable and tend to expand when maternally 
transmitted.  Longer premutation alleles are more unstable than shorter premutation 
alleles, and more likely to lead to full mutation alleles in offspring than shorter ones.  The 
length of the repeat in a premutation allele in a female is correlative to the likelihood of 
expansion to a full, symptomatic, mutation in her offspring.  As a male does not pass an 
X chromosome to his sons, the male’s FMR1 allelic status does not affect the likelihood 
of FXS in his offspring.  People carrying premutation alleles are usually asymptomatic, 
but in some cases will develop problems later in life including fragile X-associated 
tremor ataxia syndrome (FXTAS) and premature ovarian failure (FXPOI).  A third class 
of people has “full mutation” (>200 and often >500 repeats) alleles.  In these people, FXS 
is always penetrant in males and is 50% penetrant in females. 
 
1.4 FXS Pathology 
Morphologically, cerebral cortical autopsies from FXS patients show abnormal 
dendritic spine morphology (Irwin et al., 2001).  Behaviorally, the most prominent 
phenotype of FXS in humans is intellectual disability; patients will have IQ values 
generally between 20 and 70.  Short-term memory for complex information, visuospatial 
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skills and speech are particularly affected.  Speech development is often delayed in FXS 
children.  Some patients also display hyperactivity, hypersensitivity toward sensory 
stimuli and attention deficit disorder (Penagarikano et al., 2007).  Interestingly, between 
15% and 50% of FXS patients display autistic behavior (poor visual contact, tactile 
defensiveness, repetitive behaviors).  FXTAS and autism share some symptoms with 
FXS, which may indicate that related synaptic development problems may underlie all 
three syndromes.  It has been proposed that mutations in FMR1 may be the most common 
single-gene cause of autism. 
  
1.5 FMRP 
In order to understand the pathogenesis of FXS and develop therapeutic strategies, 
we must understand its underlying cause: the loss of function of FMRP.  While FMRP is 
widely expressed in fetal and adult tissues, its expression is most pronounced in the brain 
and testis, where major FXS symptoms (mental retardation and macroorchidism) 
manifest (Warren and Nelson, 1994).  FMRP is a selective RNA-binding protein that can 
form a messenger ribonucleoprotein (mRNP) with polyribosomes (Ashley et al., 1993).  
FMRP has been shown to associate with actively translating ribosomes (Jin and Warren, 
2003).  Moreover, a current model postulates that FMRP is involved in synaptic plasticity 
because it regulates mRNA transport and local synaptic protein synthesis (Figure 1; Jin et 
al., 2004b).  FMRP is thought to bind to approximately 4 percent of fetal human brain 
mRNAs in vitro (Brown et al., 1998).  One theory of how FMRP regulates mRNA 
translation is that it recognizes its target mRNAs directly.  Alternatively, there is 
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evidence that FMRP may require accessory factors such as a miRNA-containing RISC 
(miRISC) in order to bind to and regulate target mRNAs (Figure 3; Li and Jin, 2009).  
The human FMR1 gene is approximately 38 kilobases long and contains 17 exons 
(Figure 2; Ashley et al., 1993).  Through alternative splicing, the human FMR1 gene can 
generate at least 12 different proteins between 67 and 80 kDa (Devys et al., 1993).  The 
FMRP protein has two sequence motifs characteristic of RNA binding proteins.  First, a 
cluster of arginine and glycine residues known as the RGG box has been shown to bind to 
a G quartet structure formed by some mRNAs (Darnell et al., 2001).  The G quartet is an 
RNA loop structure with a planar conformation of four guanine residues that is stabilized 
by Hoodsteen base pairs (Figure 4).  Several of these planar quartets can stack to form the 
characteristic quadraplex recognized by FMRP.  Second, FMRP has two heterogeneous 
nuclear ribonucleoprotein K homology (KH) domains.  These are shown to bind a RNA 
tertiary structure known as a “kissing complex” (Figure 4; Darnell et al., 1993).   
FMRP is also believed to interact with target RNAs through several other 
conserved regulatory elements.  FMRP has been found to bind RNA ligands containing U 
rich sequences of 5-23 bases of repeating U pentamers (Figure 4; Chen et al., 2003).  
There is also controversial evidence that FMRP can interact with some target mRNAs via 
the novel noncoding BC1 RNA (Zalfa et al., 2005; Iacoangeli et al., 2007).  Of particular 
interest to work presented in this thesis, FMRP has been found to have both biochemical 
and genetic interactions with components of the miRNA pathway (Zhang et al., 2001; 
Ishizuka et al., 2002; Jin et al., 2004a).  Thus, FMRP may regulate neuronal translation 








FIGURE 3.  Model of miRNA- and FMRP-mediated mRNA regulation.  Mature 
miRNAs are loaded onto the RISC and bind to target mRNAs through complementary 
base pairing.  There are several potential mechanisms of down- regulation of mRNA 
expression by miRNA expression.  The miRISC could bind the mRNA directly and target 
it for degradation or translational repression.  Alternatively, FMRP may associate with 
the miRISC and facilitate binding to target mRNAs.  Cooperative action between FMRP 
and the miRISC could then direct the mRNA for decay or translational repression.  










FIGURE 4.  Conserved RNA tertiary structures recognized by FMRP.  a) G quartet: 
an RNA loop structure with a planar conformation of four guanine residues that is 
stabilized by Hoodsteen base pairs.  Several of these planar quartets can stack to form a G 
quadraplex.  b) U pentamer: a U rich sequence that forms a characteristic tertiary 
structure. and  c) Kissing complex: a complex “loop-loop pseudoknot” tertiary structure 
(Penagarikano et al., 2007).  Figure adapted from Penagarikano et al. (2007). 
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1.6 miRNAs 
miRNAs are short (~21-22 nucleotides) non-coding regulatory RNAs that 
modulate gene expression post-transcriptionally (Li and Jin, 2009).  miRNAs down-
regulate expression of target mRNAs by binding specifically with antisense sequences in 
the 3’ UTR, although there is evidence that they can bind to sequences in the 5’ UTR and 
protein coding region (Breving et al., 2010).  Briefly, miRNAs are transcribed in the 
nucleus as primary transcripts (pri-miRNAs) from hundreds to thousands of nucleotides 
long.  The pri-miRNA forms a secondary hairpin structure that is recognized and cleaved 
by the RNAse III enzyme Drosha yielding a precursor RNA of approximately 80 
nucleotides.  The pre-miRNA is exported to the cytoplasm where it is cleaved by the 
RNAse III enzyme Dicer in concert with a dsRNA binding protein into the mature 
miRNA.  One strand of miRNA is then incorporated into the RNA-induced silencing 
complex (RISC) and the other is typically degraded.  It is believed that the miRNA 
guides the RISC to its target, where a complimentary base pairing between the miRNA 
and the target mRNA leads to down-regulation of the target’s expression, either by 





FIGURE 5.  General pathway for miRNA biosynthesis.  1) Within the nucleus, the 
miRNA gene is transcribed by Polymerase II resulting in a pri-miRNA precursor 
averaging from 100’s to 1000’s of nucleotides long.  2) The stem-loop secondary 
structures of the pri-miRNA are recognized by the Drosha Microprocessor complex and 
cleaved into a ~70 nucleotide long pre-miRNA hairpin structure which is exported from 
the nucleus into the cytoplasm by the Exportin-5/Ran-GTP complex.  3) In the 
cytoplasm, the pre-miRNA associates with the RNAse-III type enzyme DICER, The 
mammalian TAR RNA-binding protein (TRBP; loquacious in Drosophila), and possibly 
an Argonaute protein and is cleaved to yield an ~22 nucleotide miRNA duplex.  4) One 
strand (termed the “guide” strand) of the mature miRNA associates with the RISC 
machinery leading either to translational repression or degradation of the target mRNA.  





1.7 FMRP Interacts with the miRNA Pathway 
  A current model for FMRP function is that it binds target mRNAs in the 
nucleus to form a ribonucleoprotein complex, which is then transported to the dendrites 
or spines.  At the synapse, FMRP is involved in the control of local protein synthesis via 
general and/or miRNA-mediated translational regulation (Bassell and Warren, 2008; Li 
and Jin, 2009).  Five independent lines of evidence support an interaction between the 
FMRP and miRNA pathways.  First, in vivo, mammalian FMRP interacts with miRNAs 
and components of the miRNA pathway, including Dicer and the mammalian ortholog of 
AGO1.  Furthermore, RNAs of ~20 and ~80 nucleotides (presumptive miRNAs and 
premiRNAs) immunoprecipitate with FMRP (Jin et al., 2004).  Second, in Drosophila, 
dFMRP interacts biochemically with the functional RISC proteins including dAGO1, 
dAGO2 and Dicer (Ishizuka et al., 2002).  Moreover, dFmr1 dominantly interacts with 
dAgo1 to regulate neuronal development and synaptogenesis (Jin et al., 2004).  Third, in 
Drosophila, miR-124 interacts with FMRP and controls sensory neuron structure (Xu et 
al. 2008).  Fourth, rat miR-125b and miR-132 (and others) interact with FMRP and 
control hippocampal neuron structure and function (Edbaur et al. 2010).  miR-125b 
regulates NMDAR expression (Edbaur et al., 2010).  Finally, translational control of the 
murine postsynaptic density protein 95 (PSD95) by miR-125a has recently been shown to 
require FMRP activity, although a biochemical interaction has not yet been reported 
(Muddashetty et al., 2011).   
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1.8 Futsch/ MAP1B 
 It has been clearly shown in flies and mammals that FMRP is required for 
translational regulation of the microtubule-associated protein, MAP1B, however the 
precise mechanism remains unclear (Zhang et al., 2001; Lu et al., 2004).  Microtubule-
associated proteins (MAPs) are expressed in eukaryotic cells and bind along the 
microtubule lattice.  Post-translation, MAP1A and MAP1B are cleaved into light and 
heavy chains.  Those chains are then assembled (with the separately encoded light chain 
3 subunit LC3) into mature complexes (Halpain et al., 2006).  Mammalian genomes 
usually contain three family members: MAP1A, MAP1B and MAP1S (Halpain et al., 
2006).  No obvious ortholog of any MAP1-family protein occurs in Caenorhabditis 
elegans or more primitive organisms.  The Drosophila genome only contains one MAP1-
family protein, the homolog of MAP1B, Futsch.   
Neurons in FXS patients have more long, thin, immature spines, fewer short 
spines, and an overall increased spine density, which suggests impaired synapse 
development (Irwin et al., 2001).  Similar synaptic abnormalities are observed in Fmr1 
knockout (mice and Drosophila) neurons (Comery et al., 1997; Zang et al., 2001).  
 
1.9 miRNA-Mediated Regulation of futsch 
The precise details of futsch regulation by FMRP remain unknown.  As such, 
MAP1B was considered to be a candidate for regulation by both FMRP and the miRNA 
pathway.  Bearing this in mind, identification of miRNAs that regulate Futsch, and 
elucidation of the mechanism by which they do so, would be the first logical step towards 
understanding the Futsch/FMRP regulatory pathway.  In silico analysis has indicated that 
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specific miRNAs may regulate Futsch. Here, we investigate the role of candidate 










Chapter Two: Method 
2.1 RNA Extraction and Analysis by Quantitative Real-Time PCR (qRT-PCR) 
Central Nervous System (CNS) tissues, (including ventral ganglia and optic 
lobes) were dissected from w1118 wandering 3rd instar larvae in cold HL-3 buffer then 
transferred to 700 µl QIAzol Lysis Reagant (Qiagen).  CNSs were homogenized with a 
TissueRuptor (Qiagen) for 30 seconds at high speed.  Homogenate was applied to a 
QIAshredder column (Qiagen).  After elution and chloroform precipitation, the aqueous 
phase was removed and purified using the RNeasy purification kit (Qiagen).  RNA was 
eluted from RNeasy spin columns with 30µl DEPC treated H20 then flash frozen with 
liquid nitrogen and stored at -80°C until analysis. 
Quantitative real time PCR (qRT-PCR) was performed “in house” to confirm that 
our miRNAs are expressed in the larval CNS using an iQ5 Real-Time PCR detection 
system (BioRad).  A reverse transcription reaction was performed using the SYBR Green 
based miScript miRNA RT-qPCR detection system (Qiagen).  The purified RNA was 
used in a reverse transcription reaction using the SYBR Green miScript Kit.  Mature 
miRNAs were converted to cDNA using the miScript Reverse Transcription Kit (Qiagen) 
and qRT-PCR done using the miScript SYBR Green PCR Kit (Qiagen).  The first-strand 
template was used as the template for the quantitative real-time PCR with the provided 
universal primer and miScript Primers for mature miR-315, -9a, -9b and -9c (proprietary 




2.2 miRNA Analysis by miRNA Array  
CNS tissues (ventral ganglia and optic lobes) were dissected from w1118 
wandering 3rd instar larva in cold HL-3 buffer then transferred to lysis buffer.  The RNA 
was then purified (following manufacturer’s protocol) with the miRcury RNA isolation 
Kit (Exiqon). CNSs were homogenized with a TissueRuptor (Qiagen) for 30 seconds at 
high speed.  Homogenate was applied to a QIAshredder column (Qiagen).  After elution 
and chloroform precipitation, the aqueous phase was removed then purified (following 
manufacturer’s protocol) with miRCURY RNA isolation kit (RNeasy Mini Spin Kit, 
Exiqon). The RNA was eluted from RNeasy spin columns with 30µl DEPC- treated H20. 
RNA concentration was determined using a NanoDrop ND-1000 spectrophotometer 
(Thermo Fisher Scientific) and RNA was shipped to Exiqon on dry ice for quality control 
and miRNA microarray analysis. 
Exiqon employed a chip-based hybridization miRNA microarray based on 
miRBase 14.0 (http://www.mirbase.org; Kozomara et al., 2011; Griffiths-Jones et al., 
2004; Griffiths-Jones et al., 2006; Griffiths-Jones et al., 2008), which at the time 
represented 99.3% of known Drosophila miRNAs.  The most current database release, 
miRBase 17.0 (http://www.mirbase.org; Kozomara et al., 2011; Griffiths-Jones et al., 
2004; Griffiths-Jones et al., 2006; Griffiths-Jones et al., 2008) contains a larger number 
of miRNAs, so the analysis performed using miRBase 14.0 covers only 62% coverage of 





2.3 DNA Constructs  
In order to confirm that the miRNAs identified by in silico analysis actually 
interact with and down-regulate the target mRNA (futsch), we took advantage of an 
established dual luciferase reporter system in S2 cells.  The first step was to construct the 
necessary vectors to be transfected into the S2 cells.  
Futsch firefly luciferase reporter. 
For expression in S2 cells, a PCR fragment containing the futsch 3’UTR was 
amplified from a BAC vector obtained from the Drosophila Genomics Resource Center 
(DGRC) with the upstream primer (5’‐GCCACGGGTCTGTTTATTG‐3’)  and  the 
downstream primer (5’‐ TGACTCTCTGCTCATTCTCGT‐3’ ).    The futsch 3’UTR was 
cloned first into pENTR using the Gateway system (Invitrogen) and then into the 
appropriate destination vector (pAc5.1-FLuc2:dPolyA-RFA) by LR recombination.  The 
expression of the futsch reporter in this vector is driven with a constitutively active 
Drosophila actin promoter but is lacking a 3’UTR sequence required for efficient 3’ end 
formation. 
miRNA expression vectors. 
The primary miR-9a sequence was amplified from w1118 larval genomic DNA 
using the forward primer (5’‐CACC  AATGTCCATGGGGCTAGCGA‐3’)  and  the  reverse 
primer  (5’‐TGGCCGTAAAGCCAAACTGC‐3’).  The primary miR-9b sequence was 
amplified from w1118 larval genomic DNA using the forward primer (5’‐  CACC 
GCATTGGCTTCTGCAGGTCA–3’) and the reverse primer (5’‐ 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GCGAGCATATCTCCAGGGCA  ‐3’).  The primary miR-9c sequence was amplified from 
w1118 larval genomic DNA using the forward primer (5’‐CACC 
ATTCCAGAGCATCGCCATCG‐3’) and the reverse primer (5’‐ 
GATCCCAGGGCAGCTCTGAA‐3’).  The primary miR-315 sequence was amplified from 
w1118 larval genomic DNA using the forward primer (5’‐CACC 
TCAGTGCATTGTGATGCCCA‐3’) and the reverse primer (5’–
AAATCGTCAGCGTTGAGGGG‐ 3’). 
  The CACC sequence was added to the 5’ end of the forward primers to allow 
directional cloning into pENTR.  The primary miRNA sequences were cloned into 
pENTR using a TOPO Cloning Reaction (Invitrogen kit for cloning blunt-end PCR 
product into an entry vector for the Gateway System).  The primary miRNA sequences 
were then cloned (using an LR reaction) into pAC5.1-RFA.  The expression of the 
miRNA is driven with a constitutive Drosophila actin promoter and an SV40 3’UTR is 
cloned downstream of the primary miRNA sequence to ensure robust expression. 
Renilla luciferase transfection control. 
In order to normalize the reporter expression reading results for differences in 
transfection efficiency between wells, we used a Renilla luciferase vector.  The Renilla 
luciferase is similar to firefly luciferase, but is derived from the Renilla reniformis polyp 
(known as the “sea pansy”).  Renilla luciferase cloned into pAc5.1 (Invitrogen) served as 
a transfection control.  The expression of the Renilla luciferase protein is driven with a 
constitutive actin promoter and contains an SV40 3’UTR cloned downstream of the 
primary miRNA sequence to ensure robust expression.  
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Empty expression vector.   
In order to control for quantity of DNA input into the S2 co-transfection, the same 
vector (pAC5.1-RFA) without any primary miRNA sequence is used in place of the 
miRNA expression vector. 
NERFIN reporter vector. 
The nerfin 3’UTR was amplified from w1118 genomic DNA using the forward 
primer (5’–CACC CCATGGCCCACTGAAATCGAGTGAG–3’) and the reverse primer (5’– 
CCCTGACAACCCAAAGAGAACCCAACAAG–3’) (Kuzin et al., 2004).   The nerfin 3’UTR 
was cloned using an LR reaction into the pAc5.1-FLuc2:dPolyA-RFA vector.  All 
plasmids were maxi- prepped endotoxin-free (Qiagen). 
Site directed mutagenesis of futsch reporter. 
In order to confirm that the down-regulation observed in the reporter vector is 
specifically due to the miRNA/mRNA interaction in the predicted seed region binding 
site, we created versions of the futsch reporter plasmid in which the predicted binding site 
is altered. 
The core binding regions of miR-9 and miR-315 on the futsch 3’ UTR were 
mutagenized using the Phusion Site-Directed Mutagenesis Kit by Thermo Scientific 
(product code: F-541).  Using the Firefly luciferase futsch 3’UTR reporter vector (“F-
Luc-F”) as a starting point, we introduced three nucleotide mutations at the miRNA 
binding sites.  We will refer to these mutagenized plasmids as “FLucF9mut” and 
“FLucF315mut” respectively.   
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In order to create the FLucF9mut reporter plasmid, the F-Luc-F plasmid was PCR 
amplified with the forward 5’ phosphorylated primer (5’- 
TTAGTAATCCTTGGATCAAAATAGTTTT-3’) and the reverse 5’ phosphorylated 
primer (5’-GCAAGGTAGCTTGACGTTATGCAA-3’) according to the manufacturer’s 
protocol.  The PCR product was circularized with Quick T4 DNA Ligase.  Plasmids were 
transformed into TOPO10 competent E. coli cells.  Mini-prepped DNA was sequenced 
through the mutation to confirm the mutation was successful. 
In order to create the FLucF315mut reporter plasmid, the F-Luc-F plasmid was 
PCR amplified with the forward 5’ phosphorylated primer (5’- 
TTAGTAATCCAAAGATAGCAATAGTTTT-3’) and the reverse 5’ phosphorylated 
primer (5’-GCAAGGTAGCTTGACGTTATGCAA-3’) according to the manufacturer’s 
protocol. The PCR product was circularized with Quick T4 DNA Ligase.  Plasmids were 
transformed into TOPO10 competent E. coli cells.  Mini-prepped DNA was sequenced 
through the mutation to confirm the mutation was successful. 
As a result of the site-directed mutagenesis, in the “FLuc315mut” reporter 
plasmid three base pairs within miR-315’s binding site were mutated from CAA to AGC. 
In the other, “FLucF9mut” three base pairs within the seed region binding site (common 





2.4 S2 Cells  
Drosophila S2 cells were maintained in suspension culture in 250 ml Suspension 
Culture Flasks with vent caps (Celltreat cat #229520).  Cells were maintained and 
experiments were performed in Complete Schneider’s Drosophila Medium (89% 
Schneider’s Drosophila Medium (1X), (liquid + L-Glutamine. Gibco cat #11720): 10% 
Fetal Bovine Serum (Certified, Gibco Cat #10082): 1% Penicillin-Streptomycin, (liquid, 
prepared with 5,000 units/mL Penicillin G sodium and 5,000 µg/mL Streptomycin sulfate 
in 0.85% saline, Gibco cat # 15070).  Complete media was filter sterilized with Corning 
500ml Filter System 0.22µm PES 431097 and stored at 6° Celsius.   
Transfections. 
 S2 cells were transfected in six-well plates (2x106 cells/well) using Effectene 
transfection reagent (Qiagen). All transfections were performed in triplicate (or 3 
“biological replicates”).  The transfection mixtures contained 0.1µg of firefly luciferase 
(F-Luc) reporter plasmid, 0.4µg of the Renilla transfection control, and 0.2µg of either 
plasmid expressing the miRNA primary transcripts or the pAC5.1-RFA (empty) vector 
(Zekri et al., 2009).   
Cells were split the day before transfection to ensure that cells were in an 
exponential growth phase. On the day of transfection cells were vigorously resuspended, 
taking care to wash bottom of flask vigorously to dislodge any semi-adherent cells.  
Concentration of cells was determined using an Improved Neubauer haemocytometer 
Bright Line Counting Chamber and inverted microscope.  Volume of cell suspension to 
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be used (2x106 cells /well to be transfected) was calculated.  Cells were spun down, and 
media decanted.  Cells were washed (resuspended in 1xPBS, spun down, PBS decanted) 
then resuspended in an appropriate volume of Complete media (1.6ml/well to be 
transfected).  1.6 ml cell suspension was seeded into each well (Costar 6 well, Corning 
CellBIND Surface cat# 3335). DNA (total of 0.7µg) was diluted in Buffer EC to a 
volume of 100µl/well.  For each well, a mixture of 0.1µg FLuc-F or FLucmiRmut, 0.4µg 
R-Luc (Renilla luciferase transfection control vector), and 0.2µg miRNA expression or 
empty vector was used.  All plasmids had been maxi prepped endotoxin free (Qiagen 
Endotoxin Free Maxi Prep Kit).  5.6 µl Enhancer was added to diluted DNA.  Mixture 
was vortexed for 1 second.  Mixture was incubated at room temperature for 3 minutes. 
25µl of Effectene reagent was added to mixture and mixture was vortexed for 10 seconds 
then incubated at room temperature for 7 minutes.  1 ml complete media was added to 
DNA mixture and mixed by pipetting up and down.  Solution was added drop-wise to 
wells containing cells, while gently swirling plate.  Cells were incubated for 
approximately 72 hours at 25° Celsius. 
Passive lysis. 
Cells were washed by very gently removing media from the cells with a transfer 
pipet.  Enough PBS to cover the film of cells adhered to the bottom of the well was 
gently applied then removed.  500µl of 1x Passive Lysis Buffer (prepared in nanopure-
H20 with the 5x Passive Lysis Buffer provided) was applied to washed cells (still adhered 
to bottom of well).  Cells were incubated 15 minutes at room temperature on a shaker set 




2.5 Luciferase Assays 
In order to quantitatively assay changes in Futsch expression, we utilized a dual-
luciferase reporter system (Promega).  In each experiment, firefly and Renilla luciferase 
activities were measured 3 days after transfection.  Three samples (technical replicates) 
were measured from each triplicate (biological replicate) transfection.  Firefly and Renilla 
luciferase luminescence values were measured in a 96 Well, Flat Bottom, Non-treated, 
White Polystyrene (Corning cat# 3912) assay plate using a BIO-TEK Synergy HT plate 
reader. Reagents Luciferase Assay Reagent II and Stop and Glow solution were prepared 
following manufactures instructions.  20µl of cell lysate was added to each well, then 
100µl LARII reagent was dispensed into each well. Firefly luminescence measurement 
was taken with sensitivity set to 100 (s=100). 100µl Stop and Glo reagent was added to 
each well then Renilla luminescence level was measured (s=100).    
 
2.6 Knock-down of dFMRP 
In order to investigate if the down-regulation effect observed is dependent on 
FMRP, we knocked down FMRP using RNAi. 
Creation of dsdFMR1 RNA. 
A segment of the dFMR1 coding sequence was amplified from LD09557 plasmid 
(obtained from the DGRC) using the forward primer (5’–CGTGCCCGAGAGTATGAAAT‐




ligated  into pPCR‐Script Amp SK+1  cloning vector  and  transfected  into XL10‐Gold 
cells  according  to  the  manufacturer’s protocol.  The dFMR1 pPCR plasmid was 
amplified and extracted from XL10- Gold cells.  Following manufacturer’s protocol, 
dsRNA was amplified as separate strands from dFMR1 pPCR using T3 and T7 
Megascript kits.  Separate RNA strands were annealed by combining equal quantities of 
each strand in a microfuge tube which was placed in boiling water and allowed to cool.  
dsRNA (2 micrograms/well) and reporter vectors were co-transfected into S2 cells 
according to the protocol published by Rio et al. (2011).  Luciferase reporter experiments 
were conducted essentially as described above in section 2.5.  An aliquot of the cell 
lysate was flash frozen on liquid N2 for Western analysis of FMRP levels.  
 
2.7 Western Blot of dFMR1 Knock-down 
After 72 hours of incubation, S2 cells were lysed and an aliquot run on a 
polyacrylamide gel then transferred to a membrane.  After blocking, the primary 
antibodies rabbit anti GAPDH (1:500 concentration) and mouse anti FMRP (6A15) 
(1:2,500 concentration) were applied.  After an over-night incubation and washing, anti-
mouse HRP and anti-rabbit HRP secondary antibodies (both at 1:10,000 concentration) 
were applied for two hours.  Membrane was washed, HRP developing solution applied, 








Chapter Three: Results 
3.1 miR-315 and the miR-9 Family are Predicted to Bind to the futsch 3’UTR 
To address the question of whether or not futsch expression is regulated by 
miRNAs, we first performed in silico analysis of the futsch 3’UTR sequence using the 
TargetScanFly target prediction algorithm (http://www.targetscan.org; Release 5.1 
Friedman, et al. 2009; Grimson, et al. 2007; Lewis, et al. 2005).  TargetScanFly predicts 
targets by analyzing sequence complementation between the miRNA and potential 
mRNA targets, most importantly sequence conservation in the interaction with the “seed 
region” of the miRNA (nucleotides 2-9 from the 5’ end). TargetScanFly compares the 
sequences of potential miRNA/mRNA target interactions amongst 10+ Drosophila 
species, and ranks those with high conservation to likely be most valid.  
Typically, a miRNA binds to a complementary sequence in an mRNA’s 3’UTR, 
leading to the regulation of that mRNA.  For the interaction to be effective, it is necessary 
for part of the miRNA known as the “seed region” (6-8 nucleotides long, typically close 
to the miRNA’s 5’UTR) to be a perfect match to the mRNA.   The miRNA can still 
control expression if there are mismatches between it and its target mRNA if those 
mismatches are outside of the seed region.  If the complementary match between the 
miRNA and its target mRNA are not perfect within the seed region, the over-expression 
of the miRNA should not down-regulate expression of the target mRNA (Doench and 
Sharp, 2004).   
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We queried the futsch 3’UTR and found that six miRNAs were predicted to bind 
the futsch mRNA 3’UTR, including the three members of the miR-9 family (9a, 9b, 9c), 
miR-315, miR-963, and miR-976 (Figure 6).  A miRNA family consists of several 
miRNAs with similar sequences.  These miRNAs have identical seed regions with 
identical and overlapping predicted mRNA binding sites.  miR-315 has a second 
predicted binding site in Drosophila that is less conserved between fly species.  The 
sequences of the miRNAs of interest as reported by miRBase (http://www.mirbase.org; 
Kozomara et al., 2011, Griffiths-Jones et al., 2004; Griffiths-Jones et al., 2006; Griffiths-
Jones et al., 2008) of interest are shown in Figure 6.  
 
3.2 miR-315 and the miR-9 Family are Expressed in the Drosophila Larval CNS 
We next asked whether these miRNAs of interest are expressed in the larval CNS. 
We found, both by a miRNA microarray analysis and by quantitative real-time PCR 
(qRT-PCR), that only miR-9a, -b, -c and miR-315 are expressed in the larval CNS. 
(Appendix A; data not shown). 
First, we purified RNA from control larval Drosophila CNSs (ventral ganglia and 
optic lobes) then sent samples for locked nucleic acid (LNA) miRNA microarray analysis 
(Exiqon).  At the time of our analysis, we found that of the 148 miRNAs known to be 
expressed in adult Drosophila melanogaster (miRBase 11.0; 99.3% of known miRNAs) 
79 were expressed in the CNS (Appendix A).  Since then, updated databases have been 
released, the most current being miRBase 17.0.  With the latest release, our screening 
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represents 62% of known miRNAs.  The microRNAs miR-315, -9a, -9b, and -9c were 














FIGURE 6.  futsch is predicted to be regulated by 6 miRNAs.  miR-9a, - 9b and -9c 
are from the same “family” meaning that they have identical, overlapping seed regions.  
miR-315 is predicted to bind to two places on the Drosophila futsch 3’UTR, and miR-
963 and -976 are each predicted to bind to single sites (TargetScanFly, release 5.1). 
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in our analysis, miR-976 and miR-963 were not among those expressed in the larval 
CNS. 
Next, we sought to confirm that these miRNAs were expressed in the larval CNS 
using qRT-PCR.  We performed qRT-PCR analysis on control (w1118) Drosophila larval 
CNSs.  We confirmed that miR-315 as well as the miR-9 family is expressed in the larval 
CNS (data not shown).  Together with the array results, these data demonstrate that miR-
315 and the miR-9 family are expressed in the Drosophila larval CNS. 
 
3.3 miR-315 and the miR-9 Family Repress Expression of a futsch Reporter 
We next sought to demonstrate that these miRNAs repress Futsch translation as 
predicted by our in silico target analysis.  To determine if the futsch 3’UTR is a true 
target of miRNAs -9a/b/c and -315, we used a Drosophila in vitro S2 cell system using a  
dual luciferase reporter assay (Zekri et al., 2009).   A firefly luciferase reporter (F-Luc) 
with the 3’untranslated region (UTR) of the futsch mRNA (F-LucF) was co-expressed 
with a miRNA expression vector and a Renilla luciferase (R-Luc) transfection control 
(Figure 7).   
Before we could test our primary hypothesis, we needed to confirm that the S2 
reporter system worked in our hands.  To do this, we co-transfected S2 cells with a nerfin 
reporter vector, the Renilla luciferase control vector, and the miR-9b expression vector.  
nerfin has been previously shown by others to be down-regulated by miR-9b using a 








FIGURE 7.  Diagrams of experimental plasmid constructs.  Drosophila S2 cells were 
co-transfected with three vectors: a primary miRNA expression vector, a Renilla 
luciferase (R-Luc) transfection control vector and a firefly luciferase (F-Luc) reporter 
vector in which the firefly luciferase gene’s expression is under regulation of the 3’UTR 
sequence of interest.  An endogenous actin promoter drives all three plasmids.  The SV40 
3’UTR attached to R-Luc and the primary miRNA sequences provides a strong poly (A) 
signal to ensure high levels of translation.  The reporter vector includes the endogenous 





Luc reporter (Figure 8), consistent with published results. This indicates that the S2 
reporter expression assay works in our hands. 
In order to address our primary question of whether expression of our miRNAs of 
interest down-regulates futsch expression, we then co-transfected S2 cells with three 
vectors: the luciferase futsch expression reporter vector, the Renilla transfection control, 
and each of the miRNA (or empty) expression vector individually (Figure 7).   
As we hypothesized, we found that co-expression of these miRNAs does in fact 
decrease expression of the futsch reporter (Figure 9).  miR-315 over-expression 
demonstrated the most profound repression of futsch reporter expression (82.2%, 
p<0.0006).  Each of the miR-9 family miRNAs down-regulated the futsch reporter 
expression to a lesser, but still statistically significant, extent.  miR-9a over-expression 
reduced futsch reporter levels by 62.3% (p<0.002).  miR-9b over-expression reduced 
futsch reporter levels by 58.3% (p<0.0025).  miR-9c over-expression reduced futsch 
reporter levels by 41.6% (p<0.011).  These experiments have each been repeated, with 
consistent results.  While these data indicate that futsch reporter expression is controlled 
by each of these miRNAs, it is unclear whether this regulation is due to translational 
repression or targeting of the mRNA for degradation.  This question needs to be 






FIGURE 8.  Over-expression of miR-9b suppresses expression of the F-Luc-Nerfin 
reporter.  S2 cells were transfected with a mixture of three plasmids: the F-Luc-Nerfin 
reporter, another expressing the miR-9b primary transcript, and the third expressing 
Renilla luciferase.  Firefly luciferase activity was normalized to that of Renilla 









FIGURE 9.   Over-expression of miR-9a, -9b and -9c and -315 suppress expression 
of the F-Luc-Futsch reporter.  S2 cells were transfected with a mixture of three 
plasmids: the F-Luc reporter, another expressing the miRNA primary transcript or the 
empty vector, and the third expressing Renilla luciferase.  Firefly luciferase activity was 
normalized to that of Renilla luciferase and then to the empty vector control.  Mean 












FIGURE 10.  Two new futsch reporter vectors created using site directed 
mutagenesis. (A) In order to create “FLuc315mut” we mutated three base pairs within 
miR-315’s binding site from CAA to AGC. (B) In order to create “FLuc9mut” we 
mutated three base pairs within the seed region-binding site (common to all three 
members, miR-9a, miR-9b and miR-9c) from AAA to TTG.   
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3.4 Repression of futsch Reporter Expression is Specific to the miRNA Binding Sites 
in its 3’UTR 
We next sought to confirm that the repression response was caused specifically by 
the miRNA/futsch 3’UTR interaction.  To address this issue, we used site-directed 
mutagenesis to mutate the central seed region binding sites for each of the miRNAs in the 
futsch 3’UTR  (Figure 10). 
We identified the seed region binding sites for the miR-9 family and miR-315 
using TargetScanFly (Figure 10; http://www.targetscan.org; Release 5.1 Friedman, et al., 
2009; Grimson, et al., 2007; Lewis, et al., 2005).  Members of the miR-9 family share the 
same seed region binding site.  While the entire predicted binding sites for miRNAs -
9a/b/c and -315 partially overlap, they do not share the same seed regions.  Bearing this 
in mind, we then generated two new futsch reporter vectors using site-directed 
mutagenesis.  In one, “FLuc315mut”, we mutated three base pairs within miR-315 
binding site from CAA to AGC (Figure 10A).  In the other, “FLuc9mut” we mutated 
three base pairs within the seed region binding site from AAA to TTG (Figure 10B).   
We essentially repeated the experiments outlined above in Figure 9 except used 
the appropriate mutagenized futsch 3’UTR reporter vector.  In each case, we found that 
the miRNA-mediated repression of Futsch expression is relieved when the miRNA 
binding site on the futsch 3’UTR is mutated to prevent miRNA binding (Figures 11-14).  
Interestingly, while examining miRNA repression, we observed several instances where 
miRNA-9a and miR-9c over-expression actually up-regulated the expression of the 





FIGURE 11.  Over-expression of miR-9a suppresses expression of the F-Luc-Futsch 
reporter, but does not suppress expression of the miR-9 binding site mutagenized F-
Luc-Futsch reporter.  S2 cells were transfected with a mixture of three plasmids: the F-
Luc reporter, another expressing the miRNA primary transcript or the empty vector, and 
the third expressing Renilla luciferase. Firefly luciferase activity was normalized to that 
of Renilla luciferase, and normalized values of F-Luc were then normalized to the 
reporter plasmid without miRNA. Mean values ± standard error from three biological 







FIGURE 12.  Over-expression of miR-9b suppresses expression of the F-Luc-Futsch 
reporter, but does not suppress expression of the miR-9 binding site mutagenized F-
Luc-Futsch reporter.  S2 cells were transfected with a mixture of three plasmids: the F-
Luc-Futsch reporter, another expressing the miRNA primary transcript or the empty 
vector, and the third expressing Renilla luciferase.  Firefly luciferase activity was 
normalized to that of Renilla luciferase, and normalized values of F-Luc were then 
normalized to the reporter plasmid without miRNA.  Mean values ± standard deviations 






FIGURE 13.  Over-expression of miR-9c suppresses expression of the F-Luc-Futsch 
reporter, but does not suppress expression of the miR-9 binding site mutagenized F-
Luc-Futsch reporter.  S2 cells were transfected with a mixture of three plasmids: the F-
Luc-Futsch reporter, another expressing the miRNA primary transcript or the empty 
vector, and the third expressing Renilla luciferase Firefly luciferase activity was 
normalized to that of Renilla luciferase, and normalized values of F-Luc were then 
normalized to the reporter plasmid without miRNA. Mean values ± standard error from 








FIGURE 14. Over-expression of miR-315 suppresses expression of the F-Luc-Futsch 
reporter, but does not suppress expression of the miR-315 binding site mutagenized 
F-Luc-Futsch reporter.  S2 cells were transfected with a mixture of three plasmids: the 
F-Luc-Futsch reporter, another expressing the miRNA primary transcript or the empty 
vector, and the third expressing Renilla luciferase.  Firefly luciferase activity was 
normalized to that of Renilla luciferase, and normalized values of F-Luc were then 
normalized to the reporter plasmid without miRNA. Mean values ± standard error from 







3.5 FMRP May Not Regulate futsch Expression Through Elements in the 3’UTR 
Next, we wanted to determine whether miRNA-mediated repression of the futsch 
reporter might be mediated by FMRP.  However, we first wanted to determine if 
Drosophila FMR1 could alone regulate reporter expression.  In order to address this 
question, we knocked-down dFMR1 expression in S2 cells using RNA interference 
(RNAi) and confirmed the success of the knock-down by Western Blot (Figure 15).  We 
assayed the same S2 cell lysates from the FMR1 RNAi cells using the dual luciferase 
system.  Interestingly, we found that knock down of FMR1 does not affect levels of our 
futsch expression reporter (Figure 16).  Based on these observations, we elected to not 
pursue additional experiments addressing FMRP- and miRNA-mediated control of the 










FIGURE 15.  RNAi reduces the expression of FMRP in S2 cells. Introduction of 
double stranded RNA that is complementary to the coding sequence of dFMR1 reduces 











FIGURE 16. Knock-down of FMRP does not change levels of futsch reporter 
expression. S2 cells were transfected with a mixture of the F-Luc reporter plasmid, the 
Renilla luciferase transfection control plasmid, and dFMR1 dsRNA.  Firefly luciferase 
activity was normalized to that of Renilla luciferase.  Mean values ± standard error from 













Chapter Four: Discussion 
4.1 In silico Analysis Shows That There Are Predicted Binding Sites for miRNAs in 
the futsch 3’UTR  
The miRNAs revealed by our in silico analysis are interesting for several reasons. 
Notably, the sequence of Drosophila miR-9a is perfectly identical to human miR-9_1, 
and each targets Futsch/MAP1B respectively (TargetScanFly5.2; TargetScanHuman 5.2 
(miRBase; http://www.targetscanmirbase.org; Friedman, et al., 2009; Grimson, et al., 
2007; Lewis, et al., 2005).  Moreover, murine miR-9 has been shown to co-immunopurify 
with FMRP and is involved in the control of synapse structure (Edbauer et al., 2010).  
Together, these data suggest that miR-9a is a strong candidate for co-regulation of 
FMRP-mediated control of MAP1B/Futsch expression.  Second, miR-963 and miR-976 
are predicted to bind to futsch 3’UTR, but are not expressed in the larval CNS (Figure 8; 
Appendix A). Because they are not expressed in the larval CNS, we have chosen not to 
pursue them as potential regulatory factors in larval synapse function.  However, it would 
be very interesting to see if they are involved in the control of futsch expression at 
embryonic or adult stages of development.  
 
4.2 miR-315 and the miR-9 Family are Expressed in the Drosophila CNS 
Both the miRNA microarray and qRT-PCR demonstrate that our miRNAs of 
interest are expressed in the Drosophila larval CNS.  The binding sites of the miRNAs we 
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have chosen to pursue (the miR-9 family and miR-315) have important properties.  In 
order for a miRNA to recognize and bind its target, a specific portion of the miRNA 
known as the seed region (underlined in Figure 17) must match the target mRNAs 3’UTR 
with perfect complementation.  Our in silico analysis showed the miR-9 family and miR-
315 seed regions to potentially bind to the futsch mRNA.  Interestingly, the predicted 
binding sites for the miR-9 family and miR-315 partially overlap.  There are several 
implications to these observations.  First, the binding sites for each of these miRNAs are 
mutually exclusive.  For example, a miR-9a containing RISC cannot physically occupy 
the same site as a miR-315 containing RISC.  It is unclear what the implications of this 
would be on futsch regulation.  Second, the seed regions for the miR-9 family and miR-
315 overlap by a single nucleotide.  This raises the possibility that the FLuc9mut reporter 
plasmid may also disrupt regulation by miR-315.  Finally, the presence of a second 
poorly conserved miR-315 binding site (found in Drosophila melanogaster) raises the 
possibility that futsch may be coordinately regulated by multiple miR-315 containing 
RISCs.  Perhaps this is why the repression of the futsch reporter upon co-expression of 
miR-315 with the wild type FLuc-F reporter is more robust than any member of the miR-
9 family (Figure 9). 
 
4.3 miR-315 and the miR-9 Family Specifically Repress the Expression of futsch 
While in silico analysis is a powerful tool, even with a perfect seed region match, 










FIGURE 17.  The miRNA (miR-9a, miR-9b, miR-9c (the “miR-9 family”), and miR-
315) binding sites on the futsch 3’UTR. (As predicted by TargetScanFly algorithm 
(http://www.targetscan.org; Release 5.1 Friedman, et al., 2009; Grimson, et al., 2007; 
Lewis et al., 2005) and the sequences of the miRNAs which we decided to investigate.  





validation.  It is not unprecedented for predicted binding partners to have no interaction 
in vivo.  Using the S2 luciferase reporter system, we were able to conclusively 
demonstrate that our miRNAs of interest actually down-regulate expression of our futsch 
reporter (Figure 10).  We found that the site-directed mutagenesis of the futsch 3’UTR 
binding sites for our miRNAs of interest relieve the repression caused by miRNA over-
expression, though to different extents.  Again, a possible explanation for the observation 
that miR-315 has the strongest repression effect is that there are two miR-315 binding 
sites on the futsch 3’UTR compared to the miR-9 family, which each have only one.  We 
only mutated the miR-315 site that has the highest predicted binding potential.  It would 
be interesting to mutate the second site to see if it changes reporter levels.  Also, the 
TargetScanFly algorithm (http://www.targetscan.org; Release 5.1 Friedman, et al., 2009; 
Grimson et al., 2007; Lewis et al., 2005) predicts the miR-315 binding interaction to be 
especially strong because it has a precise 8 base pair match to the futsch 3’UTR mRNA, 
as opposed to the perfect 7 base pair match for the miR-9 family miRNAs. 
 
4.4 Unexpected Findings:  miRNAs miR-9a and miR-9c Can Up-regulate the 
Translation of a Mutagenized futsch Reporter 
Our primary goal in conducting the site-directed mutagenesis experiments was to 
demonstrate that the reduction in F-Luc observed upon miRNA over-expression was 
specifically due to an interaction at the miRNA core binding site.  The site-directed 
mutagenesis experiments clearly show that this is the case. 
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Unexpectedly, in the case of miR-9a and miR-9c, we observed that miRNA over-
expression actually increased the mutated F-Luc reporter expression above the levels of 
the mutated reporter without miRNA over-expression.  We had expected site-directed 
mutation of the reporter to relieve the down-regulation caused by miRNA over-
expression, but it appears that in some cases miRNA over-expression actually enhances 
mutated reporter expression.  We theorize that this unexpected observation of increase in 
translation in the mutated futsch reporter plasmid upon over-expression of a miRNA 
might represent a novel regulatory mechanism.  Perhaps miR-9a and -9c are negative 
regulators of futsch and some other protein which itself regulates Futsch.  These two 
miRNAs share nearly 100% sequence identity outside of the seed region while miR-9b is 
considerably more divergent (Figure 17). One interesting possibility based on in silico 
data from TargetScanFly suggests that FMRP itself could be this protein.  FMRP is 
predicted to be a very strong candidate for regulation by both miR-9a and -9c.  Based on 
this observation, we propose the following working model (Figure 18).  In this model, 
miRNAs independently down-regulate expression of Futsch and FMRP.  Our data are 
consistent with this model.  If we increase miRNA expression while blocking their 
binding to futsch 3’UTR, it would follow that the repression of FMRP would continue.  
The repression of FMRP, itself a repressor of futsch, would result in an increase in futsch 











FIGURE 18. Model for miRNA repression of Futsch and FMRP.  We have found that 
miRNA over-expression down-regulates futsch expression.  We have observed that over-
expression of miRNAs sometimes increases expression of the futsch reporter in which the 
miRNA binding site has been mutated.  A possible model to explain this phenomenon is 
that miRNA over-expression (specifically miR-9a and -9c) down-regulates another 






4.5 Down-Regulation of FMRP Does Not Increase Expression of the futsch Reporter 
It has been demonstrated that FMRP is a negative regulator of futsch (Zhang et 
al., 2001).  It follows that down-regulation of FMRP would result in higher levels of 
futsch expression.  Thus, we hypothesized that we would observe increased levels of our 
futsch reporter with our (successful) down-regulation of FMRP by RNAi.  Interestingly, 
we did not find this to be the case (Figure 16).  We did not observe any significant 
change in the levels of expression of the futsch reporter.  There are several explanations 
for this observation.  First, it could be that the pathway by which these phenomena occur 
is more complicated than what has been predicted, thus down-regulation of FMRP in 
isolation from the rest of the system does not result in lower levels of futsch expression.  
Another possibility is that FMRP down-regulates expression of futsch via a direct 
interaction, but not through the 3’UTR mRNA region.  Our reporter is only sensitive to 
effects of 3’UTR futsch regulation.  If FMRP down regulates futsch by interacting with a 
different portion of the futsch mRNA (perhaps the 5’UTR or the coding sequence), levels 
of our reporter would not be affected by FMRP knock-down, as our reporter only 
contains the 3’UTR of the futsch gene.  A third possibility is that partial knockdown of 
FMRP is not sufficient to down- regulate futsch expression. It is unknown whether or not 
heterozygous null FMRP flies have normal futsch expression levels.  We were not able to 
prove or disprove the hypothesis, but our experiments suggest a potential model for the 




4.6 Potential Caveats 
In closing, one important fact to consider in the interpretation of all of our dual-
luciferase results is that the firefly luciferase reporter indicates what Futsch levels should 
be, but does not actually measure endogenous changes in expression of the Futsch 
protein.  The firefly luciferase reporter is under the control of putative regulatory 
elements in the futsch 3’UTR, but is not connected to the actual Futsch protein.   
Therefore, this reporter system has an additional caveat in that the reporter is only 
sensitive to regulation imposed on the 3’UTR of futsch.  In reality, Futsch may be under 
regulation of many factors (perhaps including FMRP) due to interactions with the coding 
sequence or 5’UTR of the futsch mRNA.  
 
4.7 Potential Future Directions 
miRNAs are believed to bind to and target mRNAs for either mRNA decay or 
translational repression.  We were not able to conclude whether RNA stability (or 
instability) is the cause of observed changes in expression, as opposed to translational 
repression.  To test this, we could perform qRT-PCR on the S2 cell lysates to determine if 
the levels of futsch mRNA are reduced upon over-expression.  A finding that futsch 
mRNA levels are lower after over-expression of miRNAs would indicate that the 
miRNAs are targeting the futsch mRNA for degradation.  If futsch mRNA levels were not 
changed by miRNA over-expression, it would indicate that the miRNAs are repressing 
the translation of Futsch, but that the futsch mRNA remains intact. 
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 There are several additional steps that could be taken to address our unanswered 
hypothesis.  It is possible that we might observe a change in futsch reporter expression if 
we were able to achieve a complete FMRP knock down, vs. the 58% knock-down we 
observed.  It is possible that a longer incubation of the S2 cells (on the order of a week or 
more) or repeated applications of dFMR1 dsRNA might achieve a greater or even 
complete reduction of FMRP expression, and perhaps an observable change in our futsch 
reporter levels.  Further, it is possible that dFMR1 dsRNA complementary to a different 
portion of the dFMR1 gene might provide more effective repression. 
 Another option is to perform essentially the opposite experiment: co-express the 
futsch reporter plasmid with a plasmid that over-expresses FMRP.  If we still did not 
observe any change in futsch reporter levels, we would have additional evidence 
indicating FMRP is not involved in regulating futsch (at least via the 3’UTR).  We could 
investigate the possibility that FMRP regulates futsch via a sequence not in the 3’UTR by 
creating a reporter under the control of a 5’regulatory sequence.   
 It would also be interesting to perform genetic epistasis experiments between 
miRNA and FMRP in S2 cells.  We could perform the experiment shown in figure 9 
while knocking-down FMR1.  If we could accomplish a 100% knock-down of FMR1, 
and we observed identical repression of the futsch reporter, that would provide additional 
evidence that miRNAs regulate futsch independently of FMRP. 
 Finally, we have produced fly lines that over-express the miRNAs -9a, -9b, -9c 
and -315 with which we could perform many in vivo assays, including, but not limited to, 
genetic interactions affecting NMJ synaptic structure and development.  
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miRNAs could play an important role in long-term synaptic plasticity underlying 
learning and memory as well as in dynamic regulation of synaptic protein synthesis in 
response to activation of neurotransmitter receptors, such as mGluRs (Muddashetty et al. 
2011).   It has been theorized that exaggerated protein synthesis (due to the lack of the 
protein synthesis inhibitor, FMRP) downstream of the mGluRs is a main cause of FXS 
pathology (Krueger and Bear, 2011).  While a treatment that blocks mGluR stimulation 
could potentially alleviate the symptoms of FXS (Figure 19), it would likely create many 
unintended side effects because the mGluR regulatory system affects a diverse array of 








FIGURE 19.  Model of FXS pathogenesis and potential pharmacological 
interventions.  The activation of mGluR receptors stimulates translation of mRNAs at 
the synapse.  Normally, FMRP represses translation of those mRNAs.  In absence of 
FMRP, the mRNAs are over-expressed, which may cause pathology.  Pharmacological 
interventions that block mGluR stimulation may alleviate FXS pathology.  Figure 









Chapter Five: Summary 
We have hypothesized that FMRP and miRNAs co-regulate expression of futsch 
(the Drosophila homologue of MAP1B).  Using an in vitro luciferase reporter system, we 
have shown that miR-315 and members of the miR-9 family selectively down-regulate 
futsch reporter translation.  We have confirmed by site-directed mutagenesis that the 
miRNA interaction with the futsch 3’UTR is specific to the miRNA seed region binding 
site.  Reporter plasmids with mutated miRNA binding sites did not display down-
regulation upon over-expression of the applicable miRNAs.  These data strongly suggest 
that miRNAs-9a/b/c and -315 regulate futsch. We have not been able to determine 
whether or not miRNAs and FMRP co-regulate futsch. The course of our experiments 
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Drosophila melanogaster 3rd Instar Larval CNS Specific miRNAs 
 
 
APPENDIX 1.  79 miRNAs are expressed in the Drosophila melanogaster 3rd instar 
larval CNS as identified by miRNA microarray analysis (Exiqon).  The database used 
to construct the profile above covered 62% of miRNAs currently known to be present in 
Drosophila melanogaster (miRBase 17.0).  However, at the time that the array was 
performed, our results covered 99.3% of known miRNAs (miRBase 14.0). Analysis was 
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